ZA983175B - 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds - Google Patents

5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds

Info

Publication number
ZA983175B
ZA983175B ZA983175A ZA983175A ZA983175B ZA 983175 B ZA983175 B ZA 983175B ZA 983175 A ZA983175 A ZA 983175A ZA 983175 A ZA983175 A ZA 983175A ZA 983175 B ZA983175 B ZA 983175B
Authority
ZA
South Africa
Prior art keywords
aminopyrido
trisubstituted
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
ZA983175A
Inventor
Shripad S Bhagwat
Richard J Perner
Yu-Gui Gu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA983175B publication Critical patent/ZA983175B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA983175A 1997-04-16 1998-04-15 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds ZA983175B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84348497A 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
ZA983175B true ZA983175B (en) 1998-10-21

Family

ID=25290123

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983175A ZA983175B (en) 1997-04-16 1998-04-15 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds

Country Status (19)

Country Link
EP (1) EP0975633A1 (en)
JP (1) JP2001520654A (en)
KR (1) KR20010006462A (en)
CN (1) CN1252069A (en)
AR (1) AR012437A1 (en)
AU (1) AU741033B2 (en)
BG (1) BG103853A (en)
BR (1) BR9809056A (en)
CA (1) CA2286592A1 (en)
CO (1) CO4940470A1 (en)
HU (1) HUP0001443A3 (en)
IL (1) IL131617A0 (en)
NO (1) NO995035L (en)
NZ (1) NZ337125A (en)
PL (1) PL336265A1 (en)
SK (1) SK140099A3 (en)
TR (1) TR199902550T2 (en)
WO (1) WO1998046604A1 (en)
ZA (1) ZA983175B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
ATE305303T1 (en) 2001-02-12 2005-10-15 Hoffmann La Roche 6-SUBSTITUTED PYRIDOPYRIMIDINES
CN107744520A (en) * 2017-10-25 2018-03-02 南京多宝生物科技有限公司 Pyrimidines are preparing the application in promoting small bowel peristalsis medicine
CN112209924B (en) * 2019-07-09 2022-04-05 中国科学院天津工业生物技术研究所 Selective adenosine A1Receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
AU7108098A (en) 1998-11-11
AR012437A1 (en) 2000-10-18
CA2286592A1 (en) 1998-10-22
SK140099A3 (en) 2000-05-16
JP2001520654A (en) 2001-10-30
BR9809056A (en) 2000-08-01
IL131617A0 (en) 2001-01-28
WO1998046604A1 (en) 1998-10-22
NO995035L (en) 1999-12-15
NZ337125A (en) 2001-06-29
PL336265A1 (en) 2000-06-19
NO995035D0 (en) 1999-10-15
CO4940470A1 (en) 2000-07-24
AU741033B2 (en) 2001-11-22
HUP0001443A2 (en) 2000-10-28
TR199902550T2 (en) 2000-04-21
BG103853A (en) 2000-06-30
HUP0001443A3 (en) 2001-01-29
EP0975633A1 (en) 2000-02-02
KR20010006462A (en) 2001-01-26
CN1252069A (en) 2000-05-03

Similar Documents

Publication Publication Date Title
EG23758A (en) Pyrrolo (2,3-d) pyrimidine compounds
PL345123A1 (en) Pyrrolo[2,3-d]pyrimidine compounds
HK1051195A1 (en) Pyrrolo(2,3-d)pyrimidine compounds.
HK1018439A1 (en) 5h-thiazolo (3,2-a) pyrimidine derivatives
SI1220856T1 (en) Pyrazolo(4,3-d)pyrimidine derivatives
AU1794697A (en) 7-alkyl-pyrrolo{2,3-d}pyrimidines
IL131293A0 (en) Pyrazine compounds
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
ZA9810920B (en) Fungicidal combinations comprising theino (2,3-d) pyrimidin-4-one
ZA9811725B (en) Triazine compounds.
IL136500A0 (en) 1,4-diazacycloheptane derivatives
IL131892A0 (en) 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds
ZA983175B (en) 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds
ZA981529B (en) Substituted 2,4-diaminopyrimidine
AU7073296A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidines
SI1087970T1 (en) PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
IL166937A (en) Uracil compounds
ZA981624B (en) Pyrazine compounds.